1. Home
  2. DUOT vs VYGR Comparison

DUOT vs VYGR Comparison

Compare DUOT & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DUOT

Duos Technologies Group Inc.

HOLD

Current Price

$11.34

Market Cap

244.3M

Sector

Technology

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.68

Market Cap

203.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DUOT
VYGR
Founded
1990
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
244.3M
203.6M
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
DUOT
VYGR
Price
$11.34
$3.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$17.00
$16.50
AVG Volume (30 Days)
713.0K
475.8K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
53.96
N/A
EPS
N/A
N/A
Revenue
$27,023,651.00
$10,135,000.00
Revenue This Year
$50.98
$34.04
Revenue Next Year
N/A
$7.92
P/E Ratio
N/A
N/A
Revenue Growth
271.16
N/A
52 Week Low
$5.78
$2.83
52 Week High
$15.28
$5.55

Technical Indicators

Market Signals
Indicator
DUOT
VYGR
Relative Strength Index (RSI) 47.92 50.42
Support Level $7.52 $3.29
Resistance Level $11.33 $4.26
Average True Range (ATR) 1.29 0.19
MACD -0.23 0.04
Stochastic Oscillator 14.21 74.11

Price Performance

Historical Comparison
DUOT
VYGR

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc delivers AI-driven technologies, edge computing infrastructure, and energy consulting services to support data-intensive and mission-critical operations. It manages, operates, engineers, software development, customer support and project implementation and management across three market segments, including rail technology deployment, Data Center co-location facilities, and behind-the-meter electrical power provision. It also continues to operate as a technology company which designs, develops, deploys, and operates intelligent technology solutions with a focus on software applications and artificial intelligence (AI) in addition to large projects, consulting, implementation, and asset management.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: